Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPD503 in Children and Adolescents With ADHD
NCT00152009Phase 3Completed
- Sponsor
- Takeda
- Start
- Jan 2003
- Primary completion
- Aug 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of guanfacine in attention deficit hyperactivity disorder (ADHD), sponsored by Takeda. Started Jan 2003; status: completed.
02
Drugs
guanfacine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00152009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00152009.